AIM ImmunoTech Statistics
Total Valuation
AIM ImmunoTech has a market cap or net worth of $16.46 million. The enterprise value is $9.32 million.
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024, before market open.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
AIM ImmunoTech has 63.32 million shares outstanding. The number of shares has increased by 3.57% in one year.
Shares Outstanding | 63.32M |
Shares Change (YoY) | +3.57% |
Shares Change (QoQ) | +6.83% |
Owned by Insiders (%) | 8.62% |
Owned by Institutions (%) | 6.86% |
Float | 53.78M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 62.90 |
Forward PS | n/a |
PB Ratio | 2.37 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 46.36 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.55.
Current Ratio | 1.17 |
Quick Ratio | 1.14 |
Debt / Equity | 0.55 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -125.85 |
Financial Efficiency
Return on equity (ROE) is -154.79% and return on invested capital (ROIC) is -97.74%.
Return on Equity (ROE) | -154.79% |
Return on Assets (ROA) | -80.04% |
Return on Capital (ROIC) | -97.74% |
Revenue Per Employee | $7,179 |
Profits Per Employee | -$1.00M |
Employee Count | 28 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.50% in the last 52 weeks. The beta is -0.39, so AIM ImmunoTech's price volatility has been lower than the market average.
Beta (5Y) | -0.39 |
52-Week Price Change | -43.50% |
50-Day Moving Average | 0.29 |
200-Day Moving Average | 0.37 |
Relative Strength Index (RSI) | 45.73 |
Average Volume (20 Days) | 274,977 |
Short Selling Information
The latest short interest is 509,932, so 0.81% of the outstanding shares have been sold short.
Short Interest | 509,932 |
Short Previous Month | 498,079 |
Short % of Shares Out | 0.81% |
Short % of Float | 0.95% |
Short Ratio (days to cover) | 1.28 |
Income Statement
In the last 12 months, AIM ImmunoTech had revenue of $201,000 and -$28.05 million in losses. Loss per share was -$0.56.
Revenue | 201,000 |
Gross Profit | 143,000 |
Operating Income | -31.59M |
Pretax Income | -31.12M |
Net Income | -28.05M |
EBITDA | -31.36M |
EBIT | -31.59M |
Loss Per Share | -$0.56 |
Full Income Statement Balance Sheet
The company has $10.06 million in cash and $3.36 million in debt, giving a net cash position of $6.70 million or $0.11 per share.
Cash & Cash Equivalents | 10.06M |
Total Debt | 3.36M |
Net Cash | 6.70M |
Net Cash Per Share | $0.11 |
Equity (Book Value) | 6.10M |
Book Value Per Share | 0.11 |
Working Capital | 1.52M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -23.25M |
Capital Expenditures | n/a |
Free Cash Flow | -23.25M |
FCF Per Share | -$0.37 |
Full Cash Flow Statement Margins
Gross Margin | 71.14% |
Operating Margin | -15,715.92% |
Pretax Margin | -13,952.74% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -11,623.83% |
Dividends & Yields
AIM ImmunoTech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.57% |
Shareholder Yield | -3.57% |
Earnings Yield | -175.06% |
FCF Yield | -145.14% |
Analyst Forecast
The average price target for AIM ImmunoTech is $3.00, which is 1,054.29% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $3.00 |
Price Target Difference | 1,054.29% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 202.96% |
EPS Growth Forecast (5Y) | -21.14% |
Stock Forecasts Stock Splits
The last stock split was on June 11, 2019. It was a reverse split with a ratio of 0.022727273:1.
Last Split Date | Jun 11, 2019 |
Split Type | Reverse |
Split Ratio | 0.022727273:1 |
Scores
AIM ImmunoTech has an Altman Z-Score of -42.18 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -42.18 |
Piotroski F-Score | 2 |